Loading…
Reported covered position: Legislative Assistant, Rep. Michelle Lujan Grisham (D-NM-1); Legislative Aide, Senator Robert Casey (D-PA)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Patients’ Right to Know Their Medication Act of 2023
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2023, and H.R. 1503, and FDA's proposed PMI rule.
Patients’ Right to Know Their Medication Act of 2023
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2024 · second_quarter · Q2
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Source: Senate LDA
| EMPLOYEE-OWNED S CORPORATIONS OF AMERICA |
| 1 |
| 2023 |
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2023, and FDA's proposed PMI rule.
Prescription Information Modernization Act of 2023
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2023, and H.R. 1503, and FDA's proposed PMI rule.
Taiwan Invasion Prevention Act
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503.
Taiwan Invasion Prevention Act
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503.
Taiwan Invasion Prevention Act
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503, and FDA's proposed PMI rule.
Taiwan Invasion Prevention Act
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503, and FDA's proposed PMI rule.
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503.
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503, and FDA's proposed PMI rule.
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503, and FDA's proposed PMI rule.
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503.
IRS task force created by the Inflation Reduction Act of 2022, H.R. 5376.
IRS task force created by the Inflation Reduction Act of 2022, H.R. 5376.
Patients’ Right to Know Their Medication Act of 2022
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 6519, the Patients' Right to Know Their Medication Act of 2022.
Patients’ Right to Know Their Medication Act of 2022
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 6519, the Patients' Right to Know Their Medication Act of 2022.
Patients’ Right to Know Their Medication Act of 2022
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 6519, the Patients' Right to Know Their Medication Act of 2022.
Patients’ Right to Know Their Medication Act of 2022
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 6519, the Patients' Right to Know Their Medication Act of 2022.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNITED WAY WORLDWIDE via VENN STRATEGIES
2024 · second_quarter · Q2
Support for nutrition programs in the farm bill.
Support for 211 line and Human-Services Emergency Logistics Program (HELP) Act.
Volunteer Income Tax Assistance (VITA), and Child Tax Credit.
Filing targets: Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2024 · second_quarter · Q2
Educating offices about paper labeling in FDA appropriations.
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2023, and FDA's proposed PMI rule.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2024 · second_quarter · Q2
Funding for programs and research relevant for people with diabetes.
Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to measures to advance the prevention of unnecessary amputations and affordable access to medication.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2024 · first_quarter · Q1
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNITED WAY WORLDWIDE via VENN STRATEGIES
2024 · first_quarter · Q1
Volunteer Income Tax Assistance (VITA), and Child Tax Credit.
Support for 211 line and Human-Services Emergency Logistics Program (HELP) Act.
Support for nutrition programs in the farm bill.
Filing targets: Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2024 · first_quarter · Q1
Educating offices about paper labeling in FDA appropriations.
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2023, and H.R. 1503, and FDA's proposed PMI rule.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2024 · first_quarter · Q1
Funding for programs and research relevant for people with diabetes.
Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to measures to advance the prevention of unnecessary amputations and affordable access to medication.
Promoting access to healthy food for people with diabetes & pre-diabetes.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2023 · fourth_quarter · Q4
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
UNITED WAY WORLDWIDE via VENN STRATEGIES
2023 · fourth_quarter · Q4
Support for 211 line and Human-Services Emergency Logistics Program (HELP) Act.
Volunteer Income Tax Assistance (VITA).
Support for nutrition programs in the farm bill.
Filing targets: Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2023 · fourth_quarter · Q4
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503, and FDA's proposed PMI rule.
Educating offices about paper labeling in FDA appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2023 · fourth_quarter · Q4
Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to measures to advance the prevention of unnecessary amputations and affordable access to medication.
Funding for programs and research relevant for people with diabetes.
Promoting access to healthy food for people with diabetes & pre-diabetes.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
UNITED WAY WORLDWIDE via VENN STRATEGIES
2023 · third_quarter · Q3
Volunteer Income Tax Assistance (VITA).
Support for 211 line and Human-Services Emergency Logistics Program (HELP) Act.
Support for nutrition programs in the farm bill.
Filing targets: Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2023 · third_quarter · Q3
Promoting access in healthy food for people with diabetes & pre-diabetes.
Funding for programs and research relevant for people with diabetes.
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2023 · third_quarter · Q3
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2023 · third_quarter · Q3
Educating offices about paper labeling in FDA appropriations.
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503, and FDA's proposed PMI rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMPLOYEE-OWNED S CORPORATIONS OF AMERICA via VENN STRATEGIES
2023 · third_quarter · Q3
Legislation and other proposed policy change impacting S Corporation ESOPs.
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Natl Economic Council (NEC), SENATE, Treasury, Dept of
UNITED WAY WORLDWIDE via VENN STRATEGIES
2023 · second_quarter · Q2
Support for 211 line and Human-Services Emergency Logistics Program (HELP) Act.
Support for nutrition programs in the farm bill.
Volunteer Income Tax Assistance (VITA).
Filing targets: Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2023 · second_quarter · Q2
Healthcare policies affecting Americans living with diabetes.
Promoting access in healthy food for people with diabetes & pre-diabetes.
Funding for programs and research relevant for people with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2023 · second_quarter · Q2
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2023 · second_quarter · Q2
Educating offices about paper labeling in FDA appropriations.
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2023 · first_quarter · 1A
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED WAY WORLDWIDE via VENN STRATEGIES
2023 · first_quarter · 1A
Support for nutrition programs in the farm bill.
Support for 211 line.
Volunteer Income Tax Assistance (VITA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2023 · first_quarter · 1A
Healthcare policies affecting Americans living with diabetes.
Funding for programs and research relevant for people with diabetes.
Promoting access in healthy food for people with diabetes & pre-diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNITED WAY WORLDWIDE via VENN STRATEGIES
2023 · first_quarter · Q1
Support for 211 line.
Volunteer Income Tax Assistance (VITA).
Support for nutrition programs in the farm bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2023 · first_quarter · Q1
Funding for programs and research relevant for people with diabetes.
Healthcare policies affecting Americans living with diabetes.
Promoting access in healthy food for people with diabetes & pre-diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2023 · first_quarter · Q1
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2023 · first_quarter · Q1
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503.
Educating offices about paper labeling in FDA appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2022 · fourth_quarter · 4A
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2022 · third_quarter · 3A
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2022 · fourth_quarter · 4A
Funding for programs and research relevant for people with diabetes.
Healthcare policies affecting Americans living with diabetes.
Promoting access in healthy food for people with diabetes & pre-diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2022 · third_quarter · 3A
Healthcare policies affecting Americans living with diabetes.
Funding for programs and research relevant for people with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2022 · fourth_quarter · 4A
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2022 · third_quarter · 3A
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNITED WAY WORLDWIDE via VENN STRATEGIES
2022 · fourth_quarter · Q4
IRS task force created by the Inflation Reduction Act of 2022, H.R. 5376.
Support for 211 line; CMS comment preparation
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2022 · fourth_quarter · Q4
Promoting access in healthy food for people with diabetes & pre-diabetes.
Funding for programs and research relevant for people with diabetes.
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2022 · fourth_quarter · Q4
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2022 · fourth_quarter · Q4
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 6519, the Patients' Right to Know Their Medication Act of 2022.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FUTURE OF PHARMACY COALITION via VENN STRATEGIES
2022 · fourth_quarter · 4T
Ensuring access to vital pharmacist services.
Ensuring access to vital pharmacist services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNITED WAY WORLDWIDE via VENN STRATEGIES
2022 · third_quarter · Q3
Support for 211 line; CMS comment preparation
IRS task force created by the Inflation Reduction Act of 2022, H.R. 5376.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE
FUTURE OF PHARMACY COALITION via VENN STRATEGIES
2022 · third_quarter · Q3
Ensuring access to vital pharmacist services.
Ensuring access to vital pharmacist services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2022 · third_quarter · Q3
Funding for programs and research relevant for people with diabetes.
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2022 · third_quarter · Q3
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2022 · third_quarter · Q3
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 6519, the Patients' Right to Know Their Medication Act of 2022.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED WAY WORLDWIDE via VENN STRATEGIES
2022 · third_quarter · RR
Federal funding strategy, support for 211 line; tax and healthcare policy.
Federal funding strategy, support for 211 line; tax and healthcare policy.
Federal funding strategy, support for 211 line; tax and healthcare policy.
CHARTED COURSE via VENN STRATEGIES
2022 · third_quarter · RR
Workforce preparedness issues, nurse staffing levels, and pandemic preparedness.
Workforce preparedness issues, nurse staffing levels, and pandemic preparedness.
Workforce preparedness issues, nurse staffing levels, and pandemic preparedness.
FUTURE OF PHARMACY COALITION via VENN STRATEGIES
2022 · second_quarter · Q2
Ensuring access to vital pharmacist services.
Ensuring access to vital pharmacist services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2022 · second_quarter · Q2
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2022 · second_quarter · Q2
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2022 · second_quarter · Q2
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 6519, the Patients' Right to Know Their Medication Act of 2022.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2022 · first_quarter · Q1
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 6519, the Patients' Right to Know Their Medication Act of 2022.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Federal funding strategy, support for 211 line; tax and healthcare policy.